StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research note issued to investors on Friday. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Athersys Trading Up 99,900.0 %
ATHX stock opened at $0.00 on Friday. The company has a market cap of $61,719.00, a P/E ratio of 0.00 and a beta of -0.90. Athersys has a 12-month low of $0.01 and a 12-month high of $1.99.
Athersys Company Profile
Featured Stories
- Five stocks we like better than Athersys
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- How to Build the Ultimate Everything ETF Portfolio
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
